The role of taurine in the pathogenesis of the cardiomyopathy of insulin-dependent diabetes mellitus

Cardiovascular Research

Volumn 46, Issue 3, 2000, Pages 393-402

  Militante, Julius D ^a   Lombardini, John B ^a   Schaffer, Stephen W ^b  

^a TEXAS TECH UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiomyopathy; Diabetes; Energy metabolism; Protein phosphorylation

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ALLOXAN; INSULIN; PYRUVATE DEHYDROGENASE; TAURINE;

CARDIOMYOPATHY; ENERGY METABOLISM; FOOD INTAKE; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; TISSUE LEVEL;

ANIMALS; CARDIOMYOPATHIES; DIABETES MELLITUS, EXPERIMENTAL; ENERGY METABOLISM; FEEDBACK; ISOENZYMES; MYOCARDIUM; PHOSPHORYLATION; PROTEIN KINASES; PROTEINS; PYRUVATE DEHYDROGENASE COMPLEX; RATS; TAURINE;

EID: 0034072711     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00025-0     Document Type: Review

References (74)

1. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 28:1979;1039-1057.
2. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 20:1997;1183-1197.
3. Mordes J.P., Rossini A.A. Animal models of diabetes. Am J Med. 70:1981;353-360.
4. Huxtable R.J. Physiological actions of taurine. Physiol Rev. 72:1992;101-163.
5. Lombardini J.B. An enzymatic derivative double isotope assay for measuring tissue levels of taurine. J Pharmacol Exp Ther. 193:1975;301-308.
6. Atlas M., Bahl J.J., Roeske W., Bressler R. In vitro osmoregulation of taurine in fetal mouse hearts. J Mol Cell Cardiol. 16:1984;311-320.
7. Goodman H.O., Shihabi Z.K. Supplemental taurine in diabetic rats: Effects on plasma glucose and triglycerides. Biochem Med Metab Biol. 43:1990;1-9.
8. Chapman R.A., Suleiman M.-S., Earm Y.E. Taurine and the heart. Cardiovasc Res. 27:1993;358-363.
9. Lombardini J.B., Liebowitz S.M. Taurine modifies calcium ion uptake and protein phosphorylation in rat heart. Iwata H., Lombardini J.B., Segawa T. Taurine and the heart. 1989;117-137 Kluwer, MA.
10. Lombardini J.B. Quantitative analysis of the combination dose-effects of taurine and taurine analogues on the phosphorylation of an ~44 Kd protein present in a mitochondrial subfraction of rat heart. J Cardiovasc Pharmacol. 28:1996;107-114.
11. Kannel W.B., McGee D.L. Diabetes and cardiovascular disease. The Framingham study. J Am Med Assoc. 241:1979;2035-2038.
12. Mahgoub M.A., Abd-Elfattah A.S. Diabetes mellitus and cardiac function. Mol Cell Biochem. 180:1998;59-64.
13. Rodrigues B., McNeill J.H. The diabetic heart: Metabolic causes for the development of a cardiomyopathy. Cardiovasc Res. 26:1992;913-922.
14. Rodrigues B., Cam M.C., McNeill J.H. Myocardial substrate metabolism: Implications for diabetic cardiomyopathy. J Mol Cell Cardiol. 27:1995;169-179.
15. Rodrigues B., Cam M.C., McNeill J.H. Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem. 180:1998;53-57.
16. Lampson W.G., Kramer J.H., Schaffer S.W. Potentiation of the actions of insulin by taurine. Can J Physiol Pharmacol. 61:1983;457-463.
17. Mozaffari M.S., Tan B.H., Lucia M.A., Schaffer S.W. Effect of drug-induced taurine depletion on cardiac contractility and metabolism. Biochem Pharmacol. 35:1986;985-989.
18. Huxtable R.J., Laird H.E. II, Lippincott S.E. The transport of taurine in the heart and the rapid depletion of tissue taurine content by guanidinoethyl sulfonate. J Pharmacol Exp Ther. 211:1979;465-471.
19. Shaffer J.E., Kocsis J.J. Methods of reducing tissue taurine levels. Schaffer S.W., Baskin S.I., Kocsis J.J. The effects of taurine on excitable tissues. 1981;219-229 Spectrum Publications, New York.
20. Stanley W.C., Lopaschuk G.D., McCormack J.G. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res. 34:1997;25-33.
21. Kerbey A.L., Randle P.J., Cooper R.H., Whitehouse S., Pask H.T., Denton R.M. Regulation of pyruvate dehydrogenase. Biochem J. 154:1976;327-348.
22. Kuo T.H., Giacomelli F., Wiener J., Lapanowski-Netzel K. Pyruvate dehydrogenase activity in cardiac mitochondria from genetically diabetic mice. Diabetes. 34:1985;1075-1081.
23. Seymour A-M L., Chatham J.C. The effects of hypertrophy and diabetes on cardiac pyruvate dehydrogenase activity. J Mol Cell Cardiol. 29:1997;2771-2778.
24. Randle P.J., Priestman D.A., Mistry S., Halsall A. Mechanisms modifying glucose oxidation in diabetes mellitus. Diabetologia. 37:(suppl. 2):1994;S155-S161.
25. Randle P.J., Priestman D.A., Mistry S., Halsall A. Glucose fatty acid interactions and the regulation of glucose disposal. J Cell Biochem. 55S:1994;1-11.
26. a kinase and synergistic inhibition by pyruvate and ADP. J Biol Chem. 254:1979;7191-7196.
27. Denton R.M., Randle P.J., Martin B.R. Stimulation by calcium ions of pyruvate dehydrogenase phosphate phosphatase. Biochem J. 128:1972;161-163.
28. Wieland O., Siess E., Schulz-Wethmar F.H., v. Funckel H.G., Winton B. Active and inactive forms of pyruvate dehydrogenase in rat heart and kidney: Effect of diabetes, fasting, and refeeding on pyruvate dehydrogenase interconversion. Arch Biochem Biophys. 143:1971;592-601.
29. Ohlen J., Siess E.A., Loffler G., Wieland O.H. The effect of insulin on pyruvate dehydrogenase interconversion in heart muscle of alloxan-diabetic rats. Diabetologia. 14:1978;135-139.
30. Brownsey R.W., Boone A.N., Allard M.F. Actions of insulin on the mammalian heart: Metabolism, pathology and biochemical mechanisms. Cardiovasc Res. 34:1997;3-24.
31. Wu P., Sato J., Zhao Y., Jaskiewicz J., Popov K.M., Harris R.A. Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isozyme 4 in rat heart. Biochem J. 329:1998;197-201.
32. Fein F.S., Strobeck J.E., Malhotra A., Scheuer J., Sonnenblick E.H. Reversibility of diabetic cardiomyopathy with insulin in rats. Circ Res. 49:1981;1251-1261.
33. Fein F.S., Malhotra A., Miller-Green B., Scheuer J., Sonnenblick E.H. Diabetic cardiomyopathy in rats: Mechanical and biochemical response to different insulin doses. Am J Physiol. 247:1984;H817-H823.
34. Zarich S.W., Nesto R.W. Diabetic cardiomyopathy. Am Heart J. 118:1989;1000-1012.
35. Shehadeh A., Regan T.J. Cardiac consequences of diabetes mellitus. Clin Cardiol. 18:1995;301-305.
36. Penpargkul S., Schaible T., Yipintsol T., Scheuer J. The effect of diabetes on performance and metabolism of rat hearts. Circ Res. 47:1980;911-921.
37. Tahiliani A.G., McNeill J.H. Effects of insulin perfusion and altered glucose concentrations on heart function in 3-day and 6-week diabetic rats. Can J Physiol Pharmacol. 64:1986;188-192.
38. Schaffer S.W., Mozaffari M.S., Cutliff C.R., Wilson G.L. Postreceptor myocardial metabolic defect in a rat model of non-insulin-dependent diabetes. Diabetes. 35:1986;593-597.
39. Kannel W.B., Hjortland M., Castelli W.P. Role of diabetes in congestive heart failure: The Framingham study. Am J Cardiol. 34:1974;29-34.
40. Chen V., Ianuzzo D., Fong B.C., Spitzer J.J. The effects of acute and chronic diabetes on myocardial metabolism in rats. Diabetes. 33:1984;1078-1084.
41. Kerbey A.L., Radcliffe P.M., Randle P.J. Diabetes and the control of pyruvate dehydrogenase in rat heart mitochondria by concentration ratios of adenosine triphosphate/adenosine diphosphate, of reduced/oxidized nicotinamide-adenine dinucleotide and of acetyl-Coenzyme A/Coenzyme A. Biochem J. 164:1977;59-519.
42. Hutson N.J., Randle P.J. Enhanced activity of pyruvate dehydrogenase kinase in rat heart mitochondria in alloxan-diabetes or starvation. FEBS Lett. 92:1978;73-76.
43. Kerbey A.L., Randle P.J. Thermolabile factor accelerates pyruvate dehydrogenase kinase reaction in heart mitochondria of starved or alloxan-diabetic rats. FEBS Lett. 127:1981;188-192.
44. Stepp L.R., Pettit F.H., Yeaman S.J., Reed L.J. Purification and properties of pyruvate dehydrogenase kinase from bovine kidney. J Biol Chem. 258:1983;9454-9458.
45. Popov K.M., Kedishvili N.Y., Zhao Y., Shimomura Y., Crabb D.W., Harris R.A. Primary structure of pyruvate dehydrogenase kinase establishes a new family of eukaryotic protein kinases. J Biol Chem. 268:1993;26602-26606.
46. Popov K.M., Kedishvili N.Y., Zhao Y., Gudi R., Harris R.A. Molecular cloning of the p45 subunit of pyruvate dehydrogenase kinase. J Biol Chem. 269:1994;29720-29723.
47. Gudi R., Bowker-Kinley M.M., Kedishvili N.Y., Zhao Y., Popov K.M. Diversity of the pyruvate dehydrogenase kinase gene family in humans. J Biol Chem. 270:1995;28989-28994.
48. Rowles J., Scherer S.W., Xi T., Majer M., Nickle D.C., Rommens J.M., Popov K.M., Harris R.A., Riebow N.L., Xia J., Tsui L.C., Bogardus C., Prochazka M. Cloning and characterization of PDK4 on 7q21.3 encoding a fourth pyruvate dehydrogenase kinase isoenzyme in human. J Biol Chem. 271:1996;22376-22382.
49. Bowker-Kinley M.M., Davis W.I., Wu P., Harris R.A., Popov K.M. Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex. Biochem J. 329:1998;191-196.
50. Priestman D.A., Mistry S.C., Kerbey A.L., Randle P.J. Purification and partial characterization of rat liver pyruvate dehydrogenase kinase activator protein (free pyruvate dehydrogenase kinase). FEBS Lett. 308:1992;83-86.
51. Reibel D.K., Shaffer J.E., Kocsis J.J., Neely J.R. Changes in taurine content in heart and other organs of diabetic rats. J Mol Cell Cardiol. 11:1979;827-830.
52. Trachtman H., Lu P., Sturman J.A. Immunohistochemical localization of taurine in rat renal tissue: Studies in experimental disease states. J Histochem Cytochem. 41:1993;1209-1216.
53. Vilchis C., Salceda R. Effect of diabetes on levels and uptake of putative amino acid neurotransmitters in rat retina and retinal pigment epithelium. Neurochem Res. 21:1996;1167-1171.
54. Malone J.I., Lowitt S., Cook W.R. Nonosmotic diabetic cataracts. Pediatr Res. 27:1990;293-296.
55. Stevens M.J., Lattimer S.A., Kamijo M., Van Huysen C., Sima A.A.F., Greene D.A. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat. Diabetologia. 36:1993;608-614.
56. Franconi F., Bernardini F., Mattana A., Miceli M., Ciuti M., Mian M., Gironi A., Anichini R., Seghieri G. Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: Effect of taurine supplementation. Am J Clin Nutr. 61:1995;1115-1119.
57. Franconi F., Micelli M., Fazzini A., Seghieri G., Caputo S., DiLeo M.A.S., Lepore D., Ghirlanda G. Taurine and diabetes: Humans and experimental models. Huxtable R.J., Azuma J., Kuriyama K., Nakagawa M., Baba A. Taurine 2. Basic and clinical aspects. 1996;579-582 Plenum Press, New York.
58. Lombardini J.B., Medina E.V. Effects of dietary inorganic sulfate, taurine, and methionine on tissue levels of taurine in the growing rat. J Nutr. 108:1978;428-433.
59. Awapara J. Absorption of injected taurine-S35 by rat organs. J Biol Chem. 225:1957;877-882.
60. Schaffer S.W. Cardiomyopathy associated with noninsulin-dependent diabetes. Mol Cell Biochem. 107:1991;1-20.
61. Schaffer S.W., Mozaffari M. Abnormal mechanical function in diabetes: Relation to myocardial calcium handling. Coronary Art Dis. 7:1996;109-115.
62. Schaffer S.W., Wilson G.L. Insulin resistance and mechanical dysfunction in hearts of Wistar rats with streptozotocin-induced non-insulin-dependent diabetes mellitus. Diabetologia. 36:1993;195-199.
63. Schaffer S.W., Tan B.H., Wilson G.L. Development of cardiomyopathy in a model of noninsulin-dependent diabetes. Am J Physiol. 248:1985;H179-H185.
64. Schaffer S.W., Mozaffari M.S., Artman M., Wilson G.L. Basis for myocardial mechanical defects associated with non-insulin-dependent diabetes. Am J Physiol. 256:1989;E25-E30.
65. Schaffer S.W., Allo S., Punna S., White T. Defective response to cAMP-dependent protein kinase in non-insulin-dependent diabetic heart. Am J Physiol. 261:1991;E369-E376.
66. Allo S.N., Lincoln T.M., Wilson G.L., Green F.J., Watanabe A.M., Schaffer S.W. Non-insulin-dependent diabetes-induced defects in cardiac cellular calcium regulation. Am J Physiol. 260:1991;C1165-C1171.
67. Lombardini J.B. Effects of taurine and taurine analogues on the phosphorylation of a 44 kDa protein present in a mitochondrial subfraction of the rat heart: Partial characterization of the 44 kDa phosphoprotein. J Mol Cell Cardiol. 26:1994;1675-1689.
68. Lombardini J.B. Identification of a specific protein in the mitochondrial fraction of the rat heart whose phosphorylation is inhibited by taurine. Amino Acids. 12:1997;139-144.
69. Lombardini J.B., Props C. Effects of kinase inhibitors and taurine analogues on the phosphorylation of specific proteins in mitochondrial fractions of rat heart and retina. Huxtable R.J., Azuma J., Kuriyama K., Nakagawa M., Baba A. Taurine 2. Basic and clinical aspects. 1996;343-350 Plenum Press, New York.
70. Lombardini J.B. Taurine depletion in the intact animal stimulates in vitro phosphorylation of an ~44-kDa protein present in the mitochondrial fraction of the rat heart. J Mol Cell Cardiol. 28:1996;1957-1961.
71. Kerbey A.L., Randle P.J. Pyruvate dehydrogenase kinase/activator in the rat heart mitochondria. Biochem J. 6:1982;103-111.
72. Sugden M.C., Holness M.J. Effects of refeeding after prolonged starvation on pyruvate dehydrogenase activities in heart, diaphragm and selected skeletal muscles of the rat. Biochem J. 262:1989;669-672.
73. Marchington D.R., Kerbey A.L., Randle P.J. Longer-term regulation of pyruvate dehydrogenase kinase in cultured rat cardiac myocytes. Biochem J. 267:1990;245-247.
74. Dallman M.F., Akana S.F., Bhatnagar S., Bell M.E., Choi S., Chu A., Horsley C., Levin N., Meijer O., Soriano L.R., Strack A.M., Viau V. Starvation: Early signals, sensors, and sequelae. Endocrinology. 140:1999;4015-4023.